5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 885-897

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of 5-HT 1A and 5-HT 2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment

By Olausson P.   Åkesson P.   Engel J.A.   Soderpalm B.  

European Journal of Pharmacology, Vol. 420, Iss. 1, 2001-05 ,pp. : 45-54

Elsevier

Access to resources Recommend Favorite

NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT 2C agonists

By Overstreet D.H.   Kralic J.E.   Morrow A.L.   Ma Z.Z.   Zhang Y.W.   Lee D.Y.W.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 3, 2003-06 ,pp. : 619-625

Elsevier

Access to resources Recommend Favorite

New 5-HT2C receptor agonists

By Bishop Michael J   Nilsson Björn M  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1691-1705

Informa Healthcare

Access to resources Recommend Favorite

5HT1F- and 5HT7-Receptor Agonists for the Treatment of Migraines

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 235-237

Bentham Science Publishers

Access to resources Recommend Favorite